MENU
+Compare
RCEL
Stock ticker: NASDAQ
AS OF
Apr 11, 04:59 PM (EDT)
Price
$8.60
Change
-$0.03 (-0.35%)
Capitalization
399.48M

RCEL Avita Medical Forecast, Technical & Fundamental Analysis

Avita is a single product company... Show more

RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RCEL with price predictions
Apr 10, 2025

RCEL in downward trend: 10-day moving average broke below 50-day moving average on April 01, 2025

The 10-day moving average for RCEL crossed bearishly below the 50-day moving average on April 01, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RCEL as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RCEL moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RCEL entered a downward trend on March 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where RCEL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RCEL just turned positive on April 10, 2025. Looking at past instances where RCEL's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

RCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.143) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.849) is also within normal values, averaging (41.794).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RCEL is expected to report earnings to fall 28.36% to -31 cents per share on May 08

Avita Medical RCEL Stock Earnings Reports
Q1'25
Est.
$-0.32
Q4'24
Missed
by $0.10
Q3'24
Missed
by $0.19
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.41
The last earnings report on February 13 showed earnings per share of -43 cents, missing the estimate of -34 cents. With 68.32K shares outstanding, the current market capitalization sits at 399.48M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
28159 Avenue Stanford
Phone
+1 833 462-8482
Employees
207
Web
https://www.avitamedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DALCX24.69N/A
N/A
Dean Mid Cap Value
DTSGX14.64N/A
N/A
Wilshire Small Company Growth Invmt
WPVIX32.62N/A
N/A
Weitz Multi Cap Equity-Institutional Cl
ACFNX62.98N/A
N/A
American Century Focused Dynamic Gr R6
DFREX37.50-0.84
-2.19%
DFA Real Estate Securities I

RCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-0.92%
MRCHF - RCEL
38%
Loosely correlated
N/A
INMD - RCEL
35%
Loosely correlated
-8.80%
MBOT - RCEL
32%
Poorly correlated
+8.48%
TRUMY - RCEL
31%
Poorly correlated
+0.37%
BLFS - RCEL
31%
Poorly correlated
-7.90%
More